eNeuro, an open-access journal from the Society for Neuroscience, publishes high-quality, broad-based, peer-reviewed research focused solely on the field of neuroscience. eNeuro embodies an emerging scientific vision that offers a new experience for authors and readers, all in support of SfN’s mission to advance understanding of the brain and nervous system.
eNeuro is indexed by Scopus, EMBASE, PubMed, PubMed Central, and Web of Science/ESCI.
- Types of Articles
- Reviewer Recognition
- Contact Information
- Letter of Recommendation *NEW*
Preparing a Manuscript
eNeuro publishes research papers that contribute to the field of neuroscience by expanding knowledge in areas of fundamental importance: Development, Neuronal Excitability, Sensory and Motor Systems, Integrative Systems, Cognition and Behavior, Novel Tools and Methods, Disorders of the Nervous System, and History, Teaching, and Public Awareness. eNeuro accepts standard and new research manuscripts in the following areas:
- New Research: Research articles that contribute to neuroscience literature by expanding knowledge in areas of fundamental importance.
- Methods/New Tools: Research papers that are well documented discussing new methods and tools useful to the scientific community.
- Theory/New Concepts: Research papers that are not necessarily based on experimental data and that question existing dogma.
- Negative Results: Research papers from authors who tried to test important hypotheses but did not get the outcome they expected. Failed preclinical tests are particularly welcome. These manuscripts must include testing the hypothesis by multiple experimental approaches, rigorously reproducing the experimental models of others that you claim to refute, and meticulous use of both positive and negative controls.
- Failure to Replicate: Research papers from authors who could not reproduce someone else’s work of significant importance despite using the same methodology (explaining why the reproduction failed is not mandatory).
- Confirmation: Research papers from authors confirming they replicated someone else’s work of significant importance and extended it.
Reviews provide timely, comprehensive, and conceptual advances and integration of a field or topic. They are peer-reviewed articles and follow the same guidelines as research papers. There is no size limit.
Societal impact papers discuss and analyze the social and ethical aspects of research. Authors should make a presubmission inquiry to the editor-in-chief if they wish to provide an article in this section.
History of Neuroscience
History of Neuroscience papers present how major discoveries were made, how a field evolved over time, the history of great neuroscientists, etc. Authors should make a pre-submission inquiry to the editor-in-chief if they wish to provide an article in this section.
Commentaries are short articles (1-2 pages) that discuss any published article or issues of special interest. They must contain a critique of the importance of the research that is undertaken or provide an alternative view or improve on an idea or a theory. Authors should make a pre submission inquiry to the editor-in-chief if they wish to provide an article in this section.
Opinions are short articles (2-4 pages) that present new ideas or discuss the state of a given research field.
Post-Publication Commentary (or Letters to the Editor)
Responses to articles may be submitted online via the "Respond to this article" link in the right sidebar of an article's Web page.
Article responses allow readers to comment on the content of articles published in eNeuro. The goal is to facilitate open exchanges on science published in eNeuro. See Letters to the Editor for more information.
eNeuro publishes a variety of invited articles including review articles, opinions, and commentaries at the invitation of the editorial board. Invited articles are peer reviewed and follow the same guidelines as research articles.
In submitting a manuscript to eNeuro, all authors must agree to abide by all relevant SfN policies,including its Guidelines for Responsible Conduct Regarding Scientific Communication. Manuscripts with multiple authors are reviewed with the explicit understanding that all authors have seen and approve of the submitted version and agree to abide by the Society's policies.
eNeuro recognizes its responsibility to ensure that questions of scientific misconduct or dishonesty in research are adequately pursued. Should scientific misconduct or dishonesty be suspected or alleged, eNeuro follows the recommended procedures outlined by COPE when dealing with allegations of misconduct. Manuscripts which have been referred to the SfN Ethics Committee because a violation of the Ethics Policy may have occurred may not be withdrawn until the Ethics Committee has rendered a final decision to the authors.
Policy on Ethics
Authors submitting papers to eNeuro must have conducted their work in strict accordance with the Society's Policy on Ethics. SfN follows the recommended procedure outlined by COPE when dealing with allegations of misconduct.
All animal experimentation reported in eNeuro must have been conducted in accordance with the Society's Policies on the Use of Animals and Humans in Neuroscience Research.
Policy on Prepublication
eNeuro generally does not consider manuscripts that have been previously published. Posting to a preprint server such as bioRxiv, ArXiv, Open Science Framework, etc. are not considered prior publication. Exceptions may be made for published abstracts, theses, and posters or manuscripts that have been posted on the Internet for the purpose of receiving commentary from the community. Online posting is typically done at a prepublication repository that has been designed for the purpose, but posting on an institutional website or other Internet location is acceptable. Articles submitted from a preprint server should comply with submission guidelines for a double-blind process as described at http://eneuro.org/information-for-authors#organization. Please contact eNeuro@sfn.org before submitting if you are uncertain that your manuscript meets the criteria for a double-blind review.
It is essential that the authors retain the copyright for any pre-published material that they submit to eNeuro, and that they are willing and able to relinquish to eNeuro any copyrights and/or licenses that eNeuro requires for publication of accepted manuscripts. Authors should realize that other journals might not consider pre-published material and that prepublication will restrict their alternatives when a manuscript is not accepted by eNeuro.
Policy on Molecular Data
eNeuro subscribes to the policies of The Journal of Biological Chemistry on protein and nucleic acid sequences and genomic and proteomic data, which it modifies as follows:
Protein and nucleic acid sequences: Newly determined nucleotide or protein sequences must be deposited in GenBank, EMBL, or the DNA Databank of Japan. Accession numbers must be reported in the manuscript and data must be available upon acceptance and publication of the manuscript. No data are to be withdrawn following publication.
Genomic and proteomic data: Authors of papers that include functional genomics data such as microarray, ChIP seq, RNA-seq, or other high-throughput data are required to deposit the data in a MIAME-compliant database such as GEO, ArrayExpress, or CYBEX and to provide accession numbers. Data must be publicly accessible upon acceptance and publication of the manuscript. No data are to be withdrawn following publication.
Authors of papers that include proteomics data should comply with the.
eNeuro subscribes to the policy of The Journal of Cell Biology on image manipulation, which it modifies as follows.
Original data: Editors reserve the right to request any original data from authors at any stage in the submission, review, or publication process, including after publication. Failure to provide requested information may result in publication delays or revocation of acceptance.
Image manipulation: All images in manuscripts accepted for publication will be scrutinized by our production department for any indication of manipulation that is inconsistent with the following guidelines. Manipulation that violates these guidelines may result in production delays or revocation of acceptance.
- No specific feature within an image may be enhanced, obscured, moved, removed, or introduced.
- Constructing figures using images taken from different parts of the same gel, or from different gels, is discouraged. But when this is necessary, it must be made explicit by the arrangement of the figure (e.g., using dividing lines) and in the text of the figure legend.
- Recordings obtained at different time points or from different sites must not be spliced together to give the appearance of a continuous record. Authors must make it clear in the figure legend how many different recordings are illustrated.
- Adjustments to images or recordings are acceptable if they are applied uniformly to all portions of the image or recording as long as they do not obscure, eliminate, or misrepresent information present in the original, including the background. Adjustments involving filtering or scaling (e.g., brightness, contrast, or color balance) must be applied to every pixel in the image or applied uniformly to the entire recording. Nonlinear adjustments (e.g., changes to gamma settings) or deleting portions of a recording (e.g., leak subtraction or stimulus artifacts) must be disclosed in the figure legend.
- The minimum resolution for images is 300 dpi.
- At the time of acceptance, authors will be required to submit uncropped images of complete gels for comparison to the prepared figures. If original data cannot be produced, the acceptance of the manuscript may be revoked.
Scale bars: All illustrations documenting results must include a bar to indicate the scale.
Molecular weights and fragment sizes: The migration of protein molecular weight size markers or nucleic acid size markers must be indicated and labeled appropriately (e.g., "kD", "nt", "bp") on all figure panels showing gel electrophoresis.
Policy on Copyright
Copyright of all material published in eNeuro remains with the authors. The authors grant the Society for Neuroscience a license to publish their work. Immediately upon publication, the work becomes available for the public to copy, distribute, or display under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.
The corresponding author may sign the license agreement on behalf of all authors, except authors who are NIH employees. Each author employed by NIH must complete and sign an NIH Publishing Agreement and attach it to an unsigned eNeuro License to Publish form.
By publishing a paper in eNeuro, the author(s) agrees to make freely available to colleagues in academic research any clones of cells, nucleic acids, antibodies, etc., that were used in the research reported and that are not available from commercial suppliers.
Authors should, when possible, honor requests for access to any form of published data for appropriate scientific use. The editors reserve the right to request any original data from authors at any stage in the review or publication process, including after publication. Failure to provide requested information may result in publication delays or revocation of acceptance.
All articles appearing in eNeuro are embargoed for release to the public until 5 p.m. Eastern Standard Time on the evening before the publication date. This policy applies to members of the media, authors, local institutions' public information officers, and anyone else with access to articles published in eNeuro. If you would like to know when an article will be posted online, please send an email inquiry to eNeuro@sfn.org. If a reporter contacts an author independent of any media relations effort, an author may share the manuscript and speak about it with the reporter as long as both parties understand that the release date is after the embargo is lifted.
NIH Public Access Policy
NIH and certain private funding agencies require that a final, electronic version of manuscripts describing research that they supported be submitted to the National Library of Medicine's PubMed Central site. Information about the NIH policy can be found at http://publicaccess.nih.gov.
As a service to our authors, eNeuro will deposit final versions of manuscripts in PubMed Central if the research was funded by NIH, Howard Hughes Medical Institute, or the Wellcome Trust. Authors funded by these agencies should accurately describe the source of funding in the acknowledgments section of their manuscripts.
Although NIH policy calls for manuscripts in PubMed Central to be freely accessible after 12 months, eNeuro will allow manuscripts to be publicly accessible through PubMed Central immediately upon publication, which is when all eNeuro articles become freely accessible.
This service will be provided automatically, without a fee, and should fulfill the obligations that grantees of these agencies have in complying with the NIH Public Access Policy for articles published in eNeuro.
No Submission Fee
Article Processing Fees
To offset expenses associated with eNeuro's editorial process — including peer-review management, data tagging and composition, copyediting, online hosting and archiving, and publishing — the journal charges a publication fee to the authors, institutions, or funders for each article published. These fees will be billed to the corresponding author upon acceptance of the article. There is no fee for invited articles. Authors are not charged for color figures, tables, or multimedia.
- Research articles, History of Neuroscience, Societal Impact, and Review articles: $1,950 for members and $2,925 for nonmembers.
- Commentaries and opinions: $975 for members and $1,465 for nonmembers.
- Wire transfer fee: $25.00.
If you would like to join SfN and take advantage of membership, visit our Member Center. Accepted manuscripts will not be published until payment has been received.
Authors retain copyright of their work and grant SfN license to publish under a Creative Commons Attribution 4.0 International (CC BY 4.0) license.
This Creative Commons license complies with funders who require an unrestricted attribution license at time of acceptance, including Wellcome Trust, Charity Open Access Fund* (COAF), and Research Councils UK* (RCUK).
For authors whose work is funded by NIH, Howard Hughes Medical Institute, Wellcome Trust, or RCUK, eNeuro will deposit the final published article to PubMed Central (PMC) and/or Europe PMC.
*COAF includes a partnership between six UK medical research charities: Arthritis Research UK, Breast Cancer Campaign, the British Heart Foundation, Cancer Research UK, Leukaemia & Lymphoma.
*RCUK includes seven different research bodies: MRC, BBSRC, AHRC, ESRC, EPSRC, NERC, STFC.
Fees will be reduced if the first and last authors are members of the Society for Neuroscience and have work addresses in one of the countries in the categories listed below. If the first and last authors work in countries in different categories, the country with the less reduced fee applies.
In an effort to aid neuroscientists working in resource-restricted countries and to broaden the dissemination of science to all areas of the world, eNeuro offers reduced submission and publication fees to scientists located in the countries classified by the World Bank as low-income economies (Category I), lower-middle-income economies (Category II), or upper-middle-income economies (Category III).
All publication fees will be reduced to 25 percent of the usual amount for Category I countries, and will be reduced to 50 percent of the usual amount for countries in Category II and III.
Fees should be paid by credit card. If a credit card cannot be used, a check or wire transfer can be accepted. Purchase orders are no longer accepted.
For payment questions, please contact eNeuro's central office at eNeuro@sfn.org.
Society for Neuroscience Central Office
Society for Neuroscience
1121 14th Street, NW, Suite 1010
Washington, DC 20005 USA
Phone: (202) 962-4000
Dr. Christophe Bernard
Faculté de Médecine Timone
27 Bd Jean MOULIN
Institut de Neurosciences des Systemes
13365 Marseille Cedex 05
Letter of Recommendation
As a service to our authors, eNeuro will provide a Letter of Recommendation to assist with their career progression on behalf of any author who has published a paper in eNeuro, if requested. The Letter of Recommendation will be signed by the Reviewing Editor of the paper, the Advisory Board member, and the Editor in Chief who can say with confidence the articles in eNeuro are highly suitable for the most competitive journals. Email questions and requests to eNeuro@sfn.org.
The quality of eNeuro depends on the effort that is generously contributed by our reviewers who have lent their expertise and time helping to ensure we publish great science. The Editors depend heavily on outside reviewers in forming opinions about papers submitted to eNeuro and would like to formally thank the following individuals for their help during the past years.
Manuscripts must be written in English. The entire text should be double-spaced, including references. Submitting an incomplete manuscript or a manuscript that does not adhere to the word limits will cause a delay in review. There are no overall length limitations.
Multiple-part papers are discouraged. Although this arrangement is sometimes necessary, authors will often be asked to collapse multiple papers into a single manuscript.
eNeuro uses a double-blind review process*, which means the identities of both the authors and reviewers are concealed throughout the review process. In order to facilitate this, authors should ensure their manuscripts are prepared in a way that does not reveal their identity. Please use the following as a guide when submitting your paper:
- Eliminate author names and contact information from anyplace in the paper. See Title Page for more information.
- Use the third person to refer to personal work. For example replace any phrases like 'as we have shown before' with 'has been shown before (Anonymous, 2007).'
- Make sure that the materials and methods section does not refer to personal work. Do not include statements such as 'using the method described in (XXX, 2007).' See Materials and Methods for more information.
- Ensure that figures do not contain any affiliation-related identifier.
- Depersonalize the work by using anonymous text where necessary. Do not include statements such as 'as we have reported before.'
- Remove self-citations and citations to unpublished work.
- Do not eliminate essential self-references or other references, but limit self-references only to papers that are relevant for those reviewing the submitted paper.
- Remove references to funding sources.
It is the responsibility of the authors to comply with the rules outlined above to ensure anonymity. If anonymity is found to be compromised, the manuscript will be pulled from review and sent back to the authors to make the necessary revisions to ensure author anonymity. If you feel necessary revisions cannot be made to meet the criteria for a double-blind review, please alert eNeuro's central office (eNeuro@sfn.org) to inquire whether your manuscript may proceed with a non-double-blind review of the manuscript.
eNeuro uses a new policy regarding statistical analysis. Please refer to Materials and Methods and the statistical table section for more information. It is the responsibility of the authors to comply with these rules. If the type of statistical analysis is not mentioned or the statistical table not included, the manuscript will be pulled from review and sent back to the authors to make the necessary revisions.
New submissions may be submitted as one PDF containing all manuscript text, figures, and tables. Revised submissions must include the manuscript text and tables prepared in Word, WordPerfect, RTF, LaTeX, or Text format. Each figure should be submitted as an EPS or TIFF file and have a resolution of at least 300 DPI. A separate title page must be provided, as noted below.
*Authors are welcome to submit a pre-submission inquiry to eNeuro@sfn.org if they feel their manuscript might not contain appropriate criteria for a double-blind review.
Supplemental Material, Source Data, and Appendices
eNeuro does not accept supplemental material or appendices. Authors should make sure all necessary data including source data and figures essential to the work are included in their article. Theoretical papers should include enough detail about the models so that the work can be replicated. Any relevant source data files should be uploaded to the system as a Source Data file type. Title them as Figure 1-1, Figure 1-2, Table 1-1, Table 1-2, etc., so they indicate which figure or table they are supporting. Each should have a legend and be cited in the manuscript text or in the table or figure legend for which they support. If these files are uploaded separately, label them accordingly on the File Description tab of the submission form.
Title Page – Separate from Manuscript Text
The title page of the manuscript should be completed using the Title Page Template.
Please include all the information listed and upload as a title page file.
Collect the following information to fill in the title page template:
- Title (50-word maximum)
- Abbreviated title (50-character maximum)
- Author names and affiliation, including postal codes
- Corresponding author with complete address, including an email address and postal code
- Number of figures, tables, multimedia (separately)
- Number of words for abstract, introduction, and discussion (separately)
- Conflicts of Interest
- Funding sources
Submitting and Corresponding Author
eNeuro distinguishes between submitting and corresponding authors. The submitting author is the author who submits the manuscript. A manuscript can have only one submitting author. The submitting author acts on behalf all other authors and is the only author with authority to resubmit, withdraw, correct, or retract manuscripts and published articles.
The corresponding author is the author responsible for responding to reader queries about the article. The submitting author has the option to also serve as corresponding author. eNeuro allows two authors to be designated as "corresponding authors." When two authors are listed, no priority is given. Corresponding authors do not have the authority to correct or retract a published article.
Authors who normally write their names in non-Latin characters may include their names in their native writing system in parentheses immediately following a transliterated version, for example, Jingbing Xue (薛晶冰). Any non-Latin languages that can be represented in Unicode characters will be accepted. This second rendering is allowed only for the original written form of a transliterated name and may not be used to include nicknames, degrees, ranks, titles, etc. Please size the name, including the surrounding parentheses, in your title page file so that it can be used as a graphic to produce the name in the final article.
The name of a formal group or consortium may be included in the author list only if that group made essential contributions to the results and there is at least one individual author in addition to the group. The individual authors must be listed first, followed by, "for [Group Name]." We do not allow "and [Group Name]." The group name must be spelled out. A statement in the acknowledgements section may specify the contribution(s) of the group and may include a URL that provides more information about the group (such as a list of its membership), but it may not list individual group members or differentiate contributions made by subgroups or individuals within the group.
The author's affiliation should be their home institution at the time when their primary contribution to the research was made. If an author's current affiliation differs, the current affiliation may be listed separately in the acknowledgements section.
Acknowledgements should be used to identify all funding sources. Acknowledgements may also be used to note intellectual, technical, or other assistance that does not warrant authorship. Individuals should be informed before the publication of any such acknowledgements and given the opportunity to decline the recognition. Promotional statements are not permitted. Funding sources should be listed first, with any acknowledgements of assistance following.
eNeuro generally does not allow dedications. The only exception is dedications to recently deceased neuroscientists who made a specific scientific contribution to the work described in the article. If the recently deceased person was one of the authors of the current paper, his or her date of death should be included. eNeuro does not allow dedications to living people.
Conflict of interest declarations are included in the acknowledgments section. For "no conflict," the preferred wording is: "The authors declare no competing financial interests." It is expected that authors submitting papers to eNeuro are in accordance with the Society's Policy on Conflict of Interest.
Manuscripts must include the following sections in the order listed:
- Abstract (250 word maximum)
- Significance Statement (120 words maximum)
- Introduction (750 words maximum, including citations)
- Materials & Methods
- Discussion (3,000 words maximum, including citations)
- Tables, Figures and Multimedia
- Mathematics and Equations
Reminder: Do NOT include the title page or any information that could reveal any author's identity.
All lines of text should be numbered. Line numbers are automatically added in Microsoft Word documents.
The abstract should be clearly written and readily comprehensible to the broad readership of eNeuro. It should provide a concise summary of the objectives, methodology (including the species studied), key results, and major conclusions of the study. The abstract should be written in complete sentences, without subheadings. An abstract is not necessary for commentary and opinion manuscripts.
Also available: Visual Abstracts
The significance statement should provide a clear explanation of the importance and relevance of the research in a manner accessible to researchers without specialist knowledge in the field and informed lay readers. The Significance Statement will appear within the paper below the abstract.
The introduction should briefly indicate the objectives of the study and provide enough background information to clarify why the study was undertaken and what hypotheses were tested.
The materials and methods section should provide sufficient information to allow other investigators to repeat the research (see also Policy Concerning Availability of Materials). Previously published work by the authors must not be referenced but rather described in detail at least for the review process. Once the paper is accepted the authors may add the relevant references. Reference to publish procedures can be made if these procedures are commonly accepted by the scientific community. The sex of the species studied should be stated. All companies from which materials were obtained should be listed. If materials were obtained from an individual, an affiliation for that individual should be listed. A manuscript that presents only a theory may omit the materials and methods section.
All animal experimentation reported in eNeuro must have been conducted in accordance with the Society's Policies on the Use of Animals and Humans in Neuroscience Research.
To preserve the double-blind process please use the following statement regarding animal use: "All animal procedures were performed in accordance with the [Author University] animal care committee's regulations." The full statement including the name of the institution should be included in the cover letter to be used if the article is accepted.
Regarding the location where human subjects were recruited please use the following statement: 'Human subjects were recruited at a location which will be identified if the article is published.' The full statement including the location should be included in the cover letter and will be used if the article is accepted.
Numerical data should be analyzed using appropriate statistical tests. The authors must state the statistical methods they have used: descriptive and/or experimental design. In the case of experimental design, the authors must indicate the type: nonrandom or random (non-inferiority or superiority).
eNeuro encourages the use of links to Web pages providing detailed specification for animal lines, reagents, software packages, etc., when it is impossible or impractical to include a unique identifier or unambiguous description. URLs should be cited in parentheses in the text. For example: "Experiments were done using C57BL mice (http://jaxmice.jax.org/strain/013636.html)."
URLs of sites providing tutorial material (e.g., http://en.wikipedia.org/) are not allowed in articles because their authority and permanence cannot be verified. URLs of personal or laboratory websites or Dropboxes are also prohibited to maintain author and reviewer anonymity.
eNeuro is pleased to be part of the Resource Identification Initiative, a project aimed at clearly identifying the key resources used in the course of scientific research. This project helps address concerns about reproducibility by providing unique searchable identifiers, Research Resource Identifiers (RRIDs), for critical reagents and tools. RRIDs link readers to external resources and enable search engines to return all papers utilizing specified antibodies, organisms, or tools. This initiative is completely voluntary for eNeuro authors. RRIDs offer an important means for ensuring reproducible methods and providing critical data to help researchers identify suitable reagents and tools. We encourage all eNeuro authors to participate.
How to Find an RRID
In order to obtain an RRID visit https://scicrunch.org/resources and enter your search term(s).
- Search tip for antibodies: searching for the catalog number usually narrows the search to only a few relevant results.
- Search tip for cell lines: searching for the catalog number of an established cell line is usually best, searching for common cell lines such as HeLa cells is expected to produce several pages of results.
- Search tip for organisms: you can include PubMed IDs (PMIDs) in your search or filter your search results by PMID, species, phenotype, and other criteria.
- Search for software tools: usually the name of the tool (MATLAB or ImageJ) or the institution where it is housed will bring back relevant results.
For more search tips and help, contact email@example.com.
How to Include RRIDs in Your Paper
Once you have located an RRID, please insert "RRID:" plus the identifier in the appropriate location in the methods section. For example:
- Antibodies: "Sections were stained with a rabbit polyclonal antibody against ERK1 (Abgent Cat# AP7251E, RRID: AB_2140114)."
- Cell Lines: "Subjects include the following cell line: CLS Cat# 300384/p699_HeLa_S3, RRID:CVCL_0058.”
- Genetically modified organisms: "Subjects in this study were Fgf9Eks/Fgf9+ mice (RRID: MGI_3840442)..."
- Software tools: "...terminals were mapped with a computer-assisted mapping program (Neurolucida, v 10; MicroBrightField RRID:nif-0000-10294)."
How to Request an RRID
When you cannot find an RRID for a model organism or antibody that you used, you can help this initiative by submitting the reagent for an identifier as detailed below. The Resource Identification Portal includes mouse, zebrafish, worm, fruit fly, and rat model organisms as well as many commercial antibodies and some lab-sourced ones. When utilizing a model organism outside those already in the relevant model organism database, visit https://scicrunch.org/resources/about/guidelines#organism to submit a new organism.” Antibodies can be added via the Antibody Registry (http://antibodyregistry.org/add); please note that login is required on that site.
The first column is the structure of the data (e.g., normal distribution).
The second column lists the statistical test.
The third column gives the observed power value of the statistical test calculated from the actual data. Confidence intervals may instead be listed.
The lines refer to the numerical values provided in the text as they appear in the results section.
|Data Structure||Type of test||Power|
The following resources offer helpful guidelines on how to report statistical results:
- Bailar, JC, Mosteller, F (1988) Guidelines for statistical reporting in articles for medical journals. Ann Intern Med, 108:266-273
- Curran-Everitt, D, Benos DJ, (2004) Guidelines for reporting statistics in journals published by the American
- Physiological Society. J Neurophysiol, 92:669-671
- Lang, TA, Secic, M (2006) How to report statistics in medicine: annotated guidelines for authors, editors and reviewers, 2nd edition, Philadelphia, PA, ACP Press
- Sarter M, Fritschy JM (2008) Eur J Neurosci 28:2363-2364.
The results section should clearly and succinctly present the experimental findings. Only results essential to establish the main points of the work should be included. There is no limit in size or number of figures and tables for this section.
Authors must provide detailed information for each analysis performed, including population size, definition of the population (e.g., number of individual measurements, number of animals, number of slices, number of times treatment was applied, etc.), and specific p values (not > or <), followed by a superscript lowercase letter referring to the statistical table provided at the end of the results section. Numerical data must be depicted in the figures with box plots.
The discussion section should include a brief statement of the principal findings, a discussion of the validity of the observations, a discussion of the findings in light of other published work dealing with the same or closely related subjects, and a statement of the possible significance of the work. Extensive discussion of the literature is discouraged.
Only published references should appear in the reference list at the end of the paper. The latest information on "in press" references should be provided. In the case of "in press" references (i.e., accepted for publication in a specific journal or book) the paper, which must be relevant for reviewers to see in order to make a well-informed evaluation should be included as a separate document text file along with the submitted manuscript. In this case, the authors recognize the loss of anonymity. "Submitted" references should be cited only in text and in the following form: (unpublished observations). If the paper is accepted, the authors can then add their names: A. B. Smith, C. D. Johnson, and E. Green, unpublished observations).The form for personal communications is similar: (F. G. Jackson, personal communication). Authors are responsible for all personal communications and must obtain written approval from persons cited before submitting the paper to eNeuro. Proof of such approval may be requested by eNeuro.
References should be cited in the text as follows: "The procedure used has been described elsewhere (Green, 1978)," or "Our observations are in agreement with those of Brown and Black (1979) and of White et al. (1980)," or, with multiple references in chronological order: "Earlier reports (Brown and Black, 1979, 1981; White et al., 1980; Smith, 1982, 1984)...."
List of references should be double-spaced and papers should be given in alphabetical order according to the surname of the first author. In two-author papers with the same first author, the order is alphabetical by the second author's name. In three-or-more-author papers with the same first author, the order is chronological. The name of the author(s) should be followed by the date in parentheses, the full title of the paper as it appeared in the original together with the source of the reference, the volume number, and the first and last pages. Do not number or bullet the references. If the author list for a paper in the references exceeds 20, the paper should be cited as Author A et al. The following illustrate the format to be used:
Hamill OP, Marty A, Neher E, Sakmann B, Sigworth F (1981) Improved patch-clamp techniques for high-resolution current recordings from cells and cell free membrane patches. Pflugers Arch 391:85-100.
Hodgkin AL, Huxley AF (1952a) The components of membrane conductance in the giant axon of Loligo. J Physiol (Lond) 116:473-496.
Hodgkin AL, Huxley AF (1952b) The dual effect of membrane potential on sodium conductance in the giant axon of Loligo. J Physiol (Lond) 116:497-506.
Hille B (1984) Ionic channels of excitable membranes. Sunderland, MA: Sinauer.
Chapter in a book
Stent GS (1981) Strength and weakness of the genetic approach to the development of the nervous system. In: Studies in developmental neurobiology: essays in honor of Viktor Hamburger (Cowan WM, ed), pp288-321. New York: Oxford UP.
Abbreviations of journal titles should follow those listed in the Index Medicus. Responsibility for correct references lies with the author(s). After manuscript revisions, authors should double-check that all in-text citations are in the reference list and that all references on the reference list have at least one corresponding in-text citation. Failure to do so will result in the delay of proof generation and possibly publication. Please make sure that the references are double-spaced and no bullets, numbers, or other listing formats are used.
Manuscripts that include illustrations (figures or multimedia) must include legends as part of the main manuscript text. A legend must be supplied for each illustration. Figures, and multimedia files should be numbered independently. The text of the article should refer to figures as "Figure 1," "Figure 2," etc., "Table 1," "Table 2," etc., multimedia files as "Movie 1," "Movie 2," etc., These text citations of figures, tables, and multimedia, need to be in numerical order, in part to aid in placing the illustrations in the proper position on the PDF page.
Illustrations must conform to eNeuro's Policy on Image Manipulation. Authors must retain their unprocessed data and metadata files, as editors may request them to aid in manuscript evaluation. If unprocessed data are unavailable, manuscript evaluation may be halted until the issue is resolved. If the original data cannot be produced, the manuscript may be rejected.
Use of Color
Illustrations must be prepared so that they are accessible to our many color-blind readers. The following sites contain useful information, tips and tools on appropriate use of color in illustrations:
The following guidelines should be observed:
- Avoid gratuitous color: Grayscale generally provides a more faithful representation when a single quantity is being displayed. Use textures or different line types rather than colors in bar plots or graphs.
- Avoid troublesome color combinations: Figures with red and green are particularly problematic. Illustrations using green/red should generally be converted to green/magenta. If no suitable combination can be found, consider presenting separate monochrome images for the different color channels. For line drawing that require color, consider redundant coding by adding different textures or line types to the colors.
Figures must be numbered independently of tables and multimedia and cited at the relevant point in the manuscript text (e.g., "Figure 1," "Figure 2"). Do not duplicate data by presenting it both in the text and in a figure.
A title should be part of the legend and not lettered onto the figure.
A legend must be included in the manuscript document after the reference list. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information, such as scale bar dimensions. Rather than stating "See text," legends should be more specific; for example, "See Results."
Figures must be submitted at the size they are to appear in eNeuro. They should be the smallest size that will convey the essential scientific information and sized appropriately: 1 column (maximum width 8.5 cm), 1.5 columns (maximum width 11.6 cm), or 2 columns (maximum width 17.6 cm).
- Initial Submission - Figures may be included in a single PDF file that contains the manuscript and all tables and figures.
- Revised Submission or Resubmission - Figures must be submitted only as separate files in TIFF or EPS format. Note: EPS images cannot use the Adobe_CoolType_Utility. This is not compatible with the current image processing guidelines used by our online hosting provider.
Color figures should be in RGB format and supplied at a minimum of 300 dpi. For figures in vector-based format, all fonts should be converted to outlines and saved as EPS (Encapsulated PostScript) to ensure that they are reproduced correctly.
For figures in vector-based format, all fonts should be converted to outlines and saved as EPS (Encapsulated PostScript) to ensure that they are reproduced correctly. For information on converting to outlines, please see: http://www.jneurosci.org/site/misc/ifa_rgbworkflow.xhtml.
Monochrome (bitmap) images must be supplied at 1200 dpi.
Grayscale images must be supplied at a minimum of 300 dpi.
Top and right borderlines (that do not contain measuring metrics) must be removed from all graph/histogram figure panels (do not box the panels in).
Please remove any two-bar graphs/histograms and explain the values in the text (Two-bar graphs/histograms are generally discouraged as they tend not to convey a stronger message with a graphic as opposed to a text format).
To ensure that your figures will appear at the highest quality, please review the detailed instructions for figure preparation with Cadmus Digital Art. To better assist our authors with digital art preparation, eNeuro has made available Cadmus' Rapid Inspector application, which alerts users when their files do not meet acceptable specifications and provides instructions on how to reformat their files to meet those specifications. Sign up at the Rapid Inspector website to download the application. If you have problems downloading the application please see the FAQs at the Cadmus site.
Tables can be included in the manuscript file as long as they only contain black and white text, but figures, must be submitted as separate files (see Figures for acceptable file formats). Any tables listing color or contain graphics will need to be turned into a figure.
Tables must be numbered independently of figures, multimedia and cited at the relevant point in the manuscript text, e.g., "Table 1," "Table 2," etc. Do not duplicate data by presenting it both in the text and in a table.
A title should appear above the table.
A legend for each table must be included in the manuscript document after the reference list. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information, such as scale bar dimensions. Rather than stating "See text," legends should be more specific; for example, "See Results."
Each table should be double-spaced. Multiple-part tables (A and B sections with separate "subtitles") should be avoided when possible, especially when there are two [different] sets [or types] of column headings. Indention of text and sometimes, additional space between lines is preferred to highlight information. Avoid the use of color or shading, bold or italic fonts, or lines to highlight information. Tables with color or shading in the table body will need to be processed as an illustration (graphic).
Visual abstracts are a new way of summarizing journal articles into a single graphical image or schematic that is designed to emphasize the main findings of the article — the take-home message. Visual abstracts are intended to help readers quickly identify papers that are most relevant to their areas of research.
"A visual abstract should be eye-catching and easy to interpret."
Authors have the option of providing a visual abstract at submission or at revision. For ease of reading, visual abstracts should have a clear beginning and end — either from top to bottom or from left to right. Keep it simple. Content should be in graphical form; keep text to a minimum. Visual abstracts are considered a part of the technical content of the article and will go through the peer review process.
The visual abstract should be submitted at the smallest size that will convey the essential scientific information. It must be submitted at the final reduced size using the following guidelines to fit in 1 column (maximum width 8.5 cm), 1.5 columns (maximum width 11.6 cm), or 2 columns (maximum width 17.6 cm).
- Initial Submission — The visual abstract may be included in a single PDF file that contains the manuscript and all tables and figures.
- Revised Submission or Resubmission — The visual abstract must be submitted only as a separate file in TIFF or EPS format. Note: EPS images cannot use the Adobe_CoolType_Utility. This is not compatible with the current image processing guidelines used by our online hosting provider.
The visual abstract should be in RGB format and supplied at a minimum solution of 300 dpi. If in vector-based format, all fonts should be converted to outlines and saved in the EPS format to ensure that they are reproduced correctly.
To ensure that the visual abstract will appear at the highest quality, please review the detailed instructions for figure preparation with Cadmus Digital Art. To better assist our authors with digital art preparation, eNeuro has made available Cadmus' Rapid Inspector application, which alerts users when their files do not meet acceptable specifications and provides instructions on how to reformat their files to meet those specifications. Sign up at the Rapid Inspector website to download the application. If you have problems downloading the application please see the FAQs at the Cadmus site.
eNeuro will publish multimedia embedded in the HTML and PDF versions of articles. Essential multimedia will be displayed in line with the article text, as is done for figures.
Multimedia files must be numbered independently of figures and tables, and cited at the relevant point in the manuscript text (e.g., "Movie 1," "Movie 2").
A title should be part of the legend and not lettered onto the multimedia file itself.
A legend must be included in the manuscript document after the reference list. Legends should include sufficient detail to be intelligible without reference to the text. Legends must define all symbols and include essential information, such as scale bar dimensions. If videos are not in real time and the time is not displayed in the video, the period represented must be stated in the legend. Rather than stating "See text," legends should be more specific; for example, "See Results."
Videos must be submitted at the size they are to appear in eNeuro. They should be the smallest size that will convey the essential scientific information and sized appropriately: 1 column (maximum width 8.5 cm), 1.5 columns (maximum width 11.6 cm), or 2 columns (maximum width 17.6 cm).
Multimedia files must be in MP4 format, and should not be larger than one megabyte.
To optimize videos for PC, tablet and smartphone viewing, we recommend formatting your videos with the following specifications:
- Video codec: H.264
- Audio codec: AAC
- Audio bit rate: 128 kbit/s
- Video resolution: 480 vertical lines or better
- Size: Maximum width of 480 pixels
To convert videos from other formats to MP4 format, the following resource is available: http://download.cnet.com/Free-MP4-Video-Converter/3000-2194_4-75628166.html.
For each video submitted, authors should provide a preview image, or poster frame that best captures the main point of the video.
Manuscripts with many mathematical characters and equations should be prepared using MathType version 6.0 or higher (available from Design Science, Inc.). Our publisher can pull equations in this format directly from the text, thereby avoiding typographical errors that frequently occur in composing equations. Manuscripts with a minimal amount of math may be prepared using word-processing tools such as Word's Equation Editor, or with features such as bold, italics, superscript and subscript together with characters in the Symbol or Greek fonts. Do not use the Wingdings or Webdings fonts.
Use nonstandard abbreviations only if a term appears three or more times (the initial appearance of the term and one other time). Spell out the term at first occurrence and introduce the abbreviation by placing it in parentheses after the term. Units should conform to the International System of Units (SI) (see the International System of Units Brochure), except for temperatures, which should be expressed in degrees Celsius.
The term "killed" is preferred to "euthanized" or "sacrificed," which are considered euphemisms. If the word "killed" is objectionable, wording can be modified. For example, "the animal was exsanguinated" instead of "the animal was killed by exsanguination."
Italics are used for binomial nomenclature, gene names, genetically modified mice (e.g., mutants) and for certain Latin terms, but not for emphasis (e.g., "the Growth group," not "the Growth group").
eNeuro does not publish letters to the editor in the print edition. Responses to articles may be submitted online via a link on the article's Web page.
Article responses allow readers to comment on the content of articles published in eNeuro. The goal is to facilitate open exchanges on science published in eNeuro. Responses can be submitted by clicking the "Respond to this article" link located in the right sidebar of an article's Web page and then following the instructions provided. Please note that communications meant solely for the authors of an article, including requests for reprints, reagents, or assistance, should be sent instead to the address listed in the footnotes of the original article (after the phrase "Correspondence should be addressed to...").
Responses should be concise: generally fewer than 250 words. It is acceptable to publish a more extensive commentary on an external site (e.g., ArXiv) and submit an abstract of that commentary with a URL as a response.
Responses will be screened for significance and appropriateness, and will usually be posted within 48 hours of receipt. Publication is at the discretion of the editors. eNeuro will not publish responses that, in our judgment, are not in the spirit of constructive scientific discourse. In addition, only one response (and optional reply to that response from the author) will be published concerning a given issue for a particular article. Although responses cannot be edited by the submitting author after publication, eNeuro editors reserve the rights to amend, edit, or remove materials at any time.
Certain material is inappropriate for responses. This includes, but is not limited to:
- Requests for medical advice or assistance
- Unpublished data (including figures or tables)
- Comments that advertise or promote specific commercial interests
- Comments that promote specific political or religious viewpoints
- Comments from authors with real or apparent conflicts of interest
- Comments that are rude, libelous, or inflammatory
- Comments that are anonymous or written under a pseudonym
We will publish your name with your response. You must provide an email address when a response is submitted, and this address will be made available to readers so they can contact you. Citations should be included when needed and should be in the same format as used in eNeuro.
All authors of responses are subject to the guidelines described in the Responsible Conduct Regarding Scientific Communications. Responses must observe any licenses or copyrights on original material.
Submitting authors are entirely responsible for the accuracy of the content of responses. However, we expect specific claims to be supported by references and opinion or speculation to be so specified in the response. Financial contributions to the work being reported should be clearly acknowledged, as should any potential conflict of interest. The proper form for citing eNeuro is as follows:
- Smith, A.B., Title of response letter (electronic response to Jones, C.D., Title of original paper. eNeuro 2015:35:19101. DOI:10.1523/eNeuro.e5813-12.2015).
Below are tips on how to revise sentences. Both articles were published in SfN's Neuroscience Quarterly.
Tips for Clear Writing
Overuse of the passive voice is a common problem in writing. Although passive voice has its place — for example, in the Methods section — in many instances it makes the manuscript dull by failing to identify the author's role in the research. Other weak writing practices are the overuse of prepositional phrases, the verb "to be," nominalizations, and noun strings. Using too many prepositional phrases causes information overloads that can confuse readers. Overuse of the weak linking verb "to be" creates unnecessarily long and imprecise sentences. Sentences with many nominalizations (noun forms of verbs) result in texts that are difficult to understand. Energize your text by transforming the noun forms of verbs back into verbs and avoid noun strings (nouns modifying nouns), which result in too much compressed information that is confusing to readers. Consider, too, where to put new and important information. Generally, readers look for new information at the end of sentences, the end of paragraphs, and the end of abstracts. Help the readelocate your most important points by using these stress positions.
Principles at Work
(See examples on eNeuro)
- Use direct, active-voice sentences.
- Limit prepositional phrases.
- Limit use of the verb "to be."
- Avoid noun forms of verbs (nominalizations).
- Limit noun strings (nouns modifying nouns).
- Put new and important information toward the end of sentences and paragraphs.
All manuscripts must be submitted to eNeuro's web-based submission site. Please refer to requirements for submission before you begin. The author who completes the submission will be designated as the corresponding author and will be responsible for handling communications with eNeuro. Co-corresponding authors may be designated on the proofs for accepted articles. The submitting author has full authority to speak for all other authors regarding withdrawal of a manuscript or correction or retraction of a published article.
At the time of submission, authors will be asked to direct their manuscript to one of eNeuro's eight publishing topics and manuscript types. Authors will also be asked to choose one or two preferred reviewing editor(s) in order of preference. Editor assignments will be made based on the expertise of the editors, load, and scheduling. Accepted manuscripts will appear in the manuscript type and publishing topic selected by the authors.
Authors are requested to identify up to five reviewers who are well qualified to referee the work and would not have a conflict of interest. Authors may also exclude specific individuals from reviewing their manuscript. The reviewing editor will typically select two independent reviewers to evaluate each paper. Once a consensus is reached by the reviewers, authors will receive a fact-based synthesis of their reviewers' comments explaining why the work was accepted or rejected, which will be published alongside the article if accepted.
Manuscripts will be returned without outside review if the reviewing editor deems that the paper is of insufficient general interest for the broad readership of eNeuro, or that the scientific quality is such that it is unlikely to receive favorable reviews. Editorial rejection allows authors to submit their papers elsewhere without further delay.
eNeuro is a member of the Neuroscience Peer Review Consortium, an alliance of neuroscience journals that have agreed to share manuscript reviews at the author's request. Its goals are to support efficient and thorough peer review of original research in neuroscience, to speed the publication of research reports, and to reduce the burden on peer reviewers. For information about the Consortium and instructions on how to forward reviews, please visit http://nprc.incf.org/authors/information-for-authors.
Requirements for Submission
When submitting your manuscript at eNeuro's web-based submission site, you will be asked to provide the following.
- The manuscript should be organized as described in Preparing Your Manuscript.
- Manuscripts must make no references to supplemental material.
- For invited revisions or resubmissions, you must submit the manuscript text in Word, WordPerfect, RTF, LaTeX, or Text format. Each figure must be uploaded as a separate file in TIFF or EPS format. Tables may be included either in the manuscript text file or as separate Word, WordPerfect, RTF, LaTeX, or Text files. PDF format is not accepted for the manuscript text, figures or tables.
- For new submissions, you may instead submit one PDF file that includes the manuscript text and all figures and tables. Pages must be numbered.
- There is a title page template that will need to be completed and uploaded separately as a title page file. For new submissions, you can submit one PDF file that includes the manuscript text and all figures and tables. Please ensure any manuscript text you submit makes no reference that would reveal the identity of any of the authors or their institutions to the reviewers. Pages must be numbered.
Title Page Information
The title page of the manuscript should be completed using the available template.
Please fill out the form completely and upload as a title page file.
Collect the following information to fill in the title page template:
- Title (50-word maximum)
- Abbreviated title (50-character maximum)
- Author names and affiliation, including postal codes
- Author contributions
- Each author must be identified with at least one of the following: Designed research, performed research, contributed unpublished reagents/analytic tools, analyzed data, or wrote the paper. Note that writing the paper by itself is not an adequate basis for authorship.
- Corresponding author with complete address, including an email address and postal code
- Number of figures, tables, and multimedia (separately)
- Number of words for abstract, introduction, and discussion (separately)
- Conflict of Interest
- Funding sources
Title (50 words maximum) and Running Title (50 characters maximum)
- Authors must direct their manuscript to the appropriate publishing topic: development, neuronal excitability, sensory and motor systems, integrative systems, cognition and behavior, novel tools and methods, disorders of the nervous system, or history, teaching, and public awareness.
- Authors are asked to identify reviewers who are well qualified to referee the work and who would not have a conflict of interest. Authors should provide the name, address, and email for each potential referee. Authors will also be asked to identify reviewers who should be excluded from refereeing. Do not include anyone with an intimate knowledge of your research.
- Authors will be asked to choose Reviewing Editor(s) in order of preference.
- Assignments will be made based on expertise of the editors, load, and availability. Authors may exclude reviewing editors from handling their manuscripts.
- It is not necessary to include a cover letter but you will be allowed to insert one on the submission form if you choose.
No Submission Fee
Detailed instructions for submitting a revised manuscript are included in the decision letter when a manuscript has been judged potentially acceptable for publication.
When submitting a revised manuscript you must:
- Submit revisions within three months of this the decision letter. If an extension is needed, contact eNeuro's central office (eNeuro@sfn.org) before the deadline.
- Sign the electronic License to Publish form once the revised manuscript is submitted. A link to the form will be available on the home page of the manuscript submission page for each author, if the corresponding author does not sign for all authors.
- Submit a point-by-point reply to the reviews showing how reviewer concerns were addressed.
- Submit the manuscript text (including tables, if any) in Word, WordPerfect, RTF, LaTeX, or Text format. In addition to a clean copy of the manuscript, you must include a version with all insertions and deletions indicated, so that reviewers can easily see the changes you have made. If revisions require adding, deleting, or reordering of figures, tables, or equations, be sure that all in-text references to such items are renumbered as well.
- If the statement "All animal procedures were performed in accordance with the authors' university animal care committee's regulations" was used in the materials and methods section to preserve the double-blind process, please be sure to provide the full statement, including the name of the institution in the cover letter so it can be used if the article is accepted.
- Double-check that all in-text citations are in the reference list and that all references on the reference list have at least one corresponding in-text citation. Only published references should appear in the reference list at the end of the paper.
- In the case of 'in press' references (i.e., accepted for publication in a specific journal or book), the paper, which must be relevant for reviewers to see in order to make a well-informed evaluation, should be included as an eNeuro.org SfN Information for Authors separate document text file along with the submitted manuscript. In this case, the authors recognize the loss of anonymity. "Submitted" references should be cited only in text and in the following form: (unpublished observations). If the paper is accepted, the authors can then add their names, i.e., (A. B. Smith, C. D. Johnson, and E. Greene, unpublished observations). Submit publication quality digital figures, one per file (see Table, Figure and Multimedia Guidelines). Check all aspects of illustrations carefully to avoid alterations in the proofs (see also the proofs section). All labels used in a figure should be explained in the legend. Double-check that all labels and symbols mentioned in the figure legend are on the final version of the figure. For questions regarding figure sizing and digital art preparation see Figures.
- Scrutinize your paper at this time for any final corrections in style or substance. Changes at the proof stage are permitted only for corrections of factual errors, printer's errors, or quality of figure reproduction. Other changes may result in a fee.
eNeuro highlights articles on the home page (http://eNeuro.org) using illustrations related to a recently published article. Images are chosen for the carousel primarily on the basis of aesthetic appeal and scientific interest. We are primarily interested in visually captivating images rather than those that serve to document experimental findings. Cartoons or metaphorical images are generally not accepted.
When submitting cover art created by someone who is not an author of the article, please have the creator fill out and sign the following permission form, License to Use Carousel Material. The signed form must be submitted with the cover art submission. Also, include an acknowledgement in the cover legend of the creator who provided the artwork.
Because of our tight production schedule, image submissions should be received within 5 days from the date of acceptance. Images to highlight your published article should be deposited at the FTP site that is described in the acceptance letter that authors receive. Please save the art in a folder named with the manuscript ID number assigned by eNeuro. If you don't have FTP software, a free program can be obtained from http://filezilla.sourceforge.net. If using a Macintosh, you can download Fetch for free for 15 days at: http://fetchsoftworks.com/. After you have deposited your image please notify us by sending an email to eNeuro@sfn.org.
Images should be formatted to the equivalent of 2 inches wide by 1 inch high with a resolution of at least 300 pixels/inch. The file should be in either EPS or TIF format.
Authors should be aware that eNeuro limits author alterations in proof. Only corrections of factual errors, copyediting errors, or in the quality of figure reproduction are allowed. This step has been taken to reduce the time required to produce eNeuro. All fees must be paid before a manuscript will be published.
To speed publication of eNeuro authors are given 48 hours from receipt of proofs to make and return corrections. Authors should notify eNeuro's central office, eNeuro@sfn.org, if the proofs should be sent to an email address other than that of the corresponding author listed on the manuscript. To purchase reprints or to inquire about production charges or invoices, refer to the contact material included with the proofs.
Once a manuscript is accepted, authors' names can only be added, deleted, or altered with the approval of the editors. Requests for changes to the author list will delay publication of a manuscript.
Authors who discover errors in articles they have published should have the corresponding author contact eNeuro's central office (eNeuro@sfn.org) with a detailed description of the correction that is needed. Corrigenda (corrections of author's errors) and errata (corrections of publisher's errors) will be published at no charge to the authors. Requests for corrections that affect the interpretation or conclusions of a published article will be reviewed by the editors.
eNeuro will retract an article at the authors' request at any time without requiring explanation unless it is under review for a possible violation of SfN's guidelines of Guidelines for Responsible Conduct Regarding Scientific Communication. The corresponding author should contact the Editor-in-Chief (eNeuroeditor@sfn.org) to request a retraction.
eNeuro will retract an article at the authors' request unless it is under review for a possible violation of SfN's Guidelines for Responsible Conduct Regarding Scientific Communication. At the authors' option, the retraction notice may simply state that the article has been retracted at the authors' request. Alternatively, the authors may provide a brief explanation of the error(s) prompting the retraction. However, statements of retraction may not assign blame to specific authors or laboratories. To request a retraction, the corresponding author should contact the editor-in-chief (eNeuroeditor@sfn.org).
In retraction statements, eNeuro clearly distinguishes between author-initiated retractions and those initiated by the editors because of violations of the Society for Neuroscience's guidelines.
The editors reserve the right to retract an article at any time after publication without the consent of the authors if an investigation by an appropriate authority reveals a violation of the Society for Neuroscience Ethics Policy.